Review
Accepted on 01 Aug 2025
A Perfect Storm: The Deadly Intersection of Sickle Cell Disease and COVID-19
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1651089
- 195 views
Type at least 3 characters
147 articles
Case Report
Accepted on 28 Jul 2025
A case of Intravascular large B-cell lymphoma and related literature review
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1639726
- 142 views
Case Report
Published on 24 Jul 2025
Balance and management of CRS and infection following CD19-targeted CAR T-cell therapy in primary refractory high-grade B-cell lymphoma: a case report
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2025.1616504
- 525 views
Review
Published on 16 Jul 2025
The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1624046
- 682 views
Case Report
Published on 15 Jul 2025
Co-occurrence of AIDS and acute promyelocytic leukemia: a case report and review of the literature
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1527938
- 468 views
Original Research
Published on 14 Jul 2025
Soluble immune checkpoint landscape in sickle cell disease links systemic inflammation, autoimmunity, and pain
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1580009
- 554 views
Brief Research Report
Published on 11 Jul 2025
The “added value” of enrolling hematological patients in clinical trials: a single-center experience
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1613099
- 496 views
Original Research
Accepted on 10 Jul 2025
Pre-infusion ferritin a predictive biomarker for CAR T-cell therapy in R/R multiple myeloma
in Gene Therapy, Cell Therapy and Hematology
Frontiers in Hematology
doi 10.3389/frhem.2025.1618331
- 321 views
Review
Published on 23 Jun 2025
Advances in Chimeric Antigen Receptor T-cell therapy for hematologic malignancies and autoimmune conditions: a review of the 2024 American Society of Hematology Annual Meeting
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2025.1610794
- 763 views
Case Report
Published on 23 Jun 2025
Case report: Clinical characteristics and genetic analysis of a familial platelet disorder associated with RUNX1 gene mutation
in Gene Therapy, Cell Therapy and Hematology
Frontiers in Hematology
doi 10.3389/frhem.2025.1608314
- 492 views
Case Report
Published on 23 Jun 2025
Case Report: Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell-directed chemotherapy for gammopathy-driven pulmonary elastolysis in acquired cutis laxa
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1502322
- 309 views
Mini Review
Published on 19 Jun 2025
Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1609642
- 883 views
Case Report
Published on 18 Jun 2025
Successful management of acute promyelocytic leukemia in the third trimester of pregnancy: a case report and review of the literature
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1553336
- 838 views
Case Report
Published on 16 Jun 2025
Case Report: Expanding the ocular horizon: subperiosteal orbital hematoma and Roth spots in known case of sickle cell disease
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1558509
- 741 views
Editorial
Published on 29 May 2025
Editorial: Investigations and management of hereditary red blood cells diseases
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1605163
- 365 views
Original Research
Published on 23 May 2025
Downregulated PTEN and aberrant JAK–STAT signal pathway in essential thrombocythemia patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1479185
- 737 views